News Results
There are 369,957 News Results
May 29, 2018
LONDON, May 30, 2018 /PRNewswire/ -- FN Media Group Presents OilPrice.com News Commentary In a matter of weeks, Canada will most likely legalize marijuana for recreational use. Expectations for a...
May 31, 2018
IMBRUVICA® (ibrutinib) in Combination with Rituximab Showed Greater Efficacy Compared to Placebo Plus Rituximab in Patients with Waldenström's Macroglobulinemia, a Rare and Incurable Form of Non-Hodgkin's Lymphoma
Jun 1, 2018
New Novartis data presented at ASCO find nearly half of CML patients treated with Tasigna® remain in remission almost three years after stopping therapy
Jun 2, 2018
Third Novartis Phase III trial shows Kisqali® combination therapy significantly improves PFS in HR+/HER2- advanced breast cancer
Jun 3, 2018
CHICAGO, June 4, 2018 /PRNewswire/ -- Not intended for UK-based media - Two-year follow-up data on meaningful durable responses, overall survival (OS) and progression-free survival (PFS) to be presented in...
Jun 5, 2018
LONDON, June 5, 2018 /PRNewswire/ -- The fourth industrial revolution has finally arrived and the future belongs to a new set of key technologies. Steve Chiavarone, portfolio manager for Federated...
Jun 6, 2018
HUNTSVILLE, Texas, June 6, 2018 /PRNewswire/ -- Mitcham Industries, Inc. (NASDAQ: MIND) ("Mitcham" or "the Company") today announced financial results for its fiscal 2019 first quarter ended April 30, 2018....
Jun 14, 2018
TITUSVILLE, N.J., June 14, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the MERCURY PE study, which showed that people with low-risk pulmonary...
Jun 21, 2018
SHANGHAI, June 21, 2018 /PRNewswire/ -- Microsoft ScaleUp Shanghai today hosted the
Jun 24, 2018
TITUSVILLE, N.J. and ORLANDO, Fla., June 24, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced late-breaking results of a new real-world analysis of more than...